As Part of the Settlement, Lupin Receives a License to Market Generic FIRDAPSE Beginning in February 2035CORAL GABLES, Fla., Aug. 25, 2025 (GLOBE NEWSWIRE) -- Catalyst Pharmaceuticals, Inc. ("Catalyst ...

Catalyst Pharmaceuticals ( NASDAQ: CPRX) said that the company and licensor SERB S.A. signed a settlement agreement with ...

Catalyst Pharmaceuticals agreed to settle its litigation against Lupin Pharmaceuticals over Lupin's application to market a generic version of Catalyst's Lambert-Eaton myasthenic syndrome drug.

Either way, fans are excited to see what the cunning con-man has been up to as of late! Being that filming for Season 4 has ...

A seductive thief takes center stage in this bold anime noir masterpiece that is the perfect next-watch for fans of Cowboy ...

The stock's recent performance reflects a positive movement, driven by financial growth and corporate actions.

Ranibizumab's indications encompass the treatment of patients with Neovascular (Wet) Age-Related Macular Degeneration, and ...

Returning cast for season 4 includes Sy, Ludivine Sagnier, Antoine Gouy, Soufiane Guerrab, Shirine Boutella, Théo Christine, and Laïka Blanc-Francard. The season comprises 8 episodes of 45 minutes, ...

Lupin has partnered with Swiss major Sandoz Group AG to market and commercialise Lupin’s biosimilar ranibizumab across ...

Sandoz will oversee commercialization of the product across the European Union (excluding Germany), Switzerland, Norway, ...

Prabhudas Lilladher is bullish on Lupin has recommended buy rating on the stock with a target price of Rs 2400 in its ...

Lupin the 3rd: The First opens with a flashback to the 1940s, as the book’s creator attempts to have it spirited away to safety, while a group of Nazis pursue its keepers.